Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Frydland

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Resuscitation|December 26, 2022
Modulation of inflammation by treatment with tocilizumab after out-of-hospital cardiac arrest and associations with clinical status, myocardial- and brain injuryMartin Abild Stengaard Meyer, Mette Bjerre, Sebastian Wiberg, et al.
European Journal of Heart Failure|July 25, 2019
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort studyOle K L Helgestad, Jakob Josiassen, Christian Hassager, et al.
European Journal of Clinical Pharmacology|May 11, 2026
Comparison of loop diuretics for chronic heart failure: a systematic review and meta-analysisSami Taleghani, Cecilie C Sørensen, Jasmin Dam Lukoschewitz, et al.
Journal of Critical Care|December 27, 2018
Mean arterial pressure during targeted temperature management and renal function after out-of-hospital cardiac arrestJohannes Grand, Christian Hassager, Matilde Winther-Jensen, et al.
European Heart Journal. Acute Cardiovascular Care|April 29, 2017
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patientsLaust Obling, Martin Frydland, Rikke Hansen, et al.
Shock (Augusta, Ga.)|May 7, 2019
Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial InfarctionAnika Klein, Sebastian Wiberg, Christian Hassager, et al.
Resuscitation|January 29, 2015
Target temperature management of 33°C and 36°C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm - a TTM sub-studyMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
European Heart Journal. Acute Cardiovascular Care|January 22, 2020
Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarctionMartin Frydland, Jacob E Møller, Matias G Lindholm, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Resuscitation|December 26, 2022
Modulation of inflammation by treatment with tocilizumab after out-of-hospital cardiac arrest and associations with clinical status, myocardial- and brain injuryMartin Abild Stengaard Meyer, Mette Bjerre, Sebastian Wiberg, et al.
European Journal of Heart Failure|July 25, 2019
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort studyOle K L Helgestad, Jakob Josiassen, Christian Hassager, et al.
European Journal of Clinical Pharmacology|May 11, 2026
Comparison of loop diuretics for chronic heart failure: a systematic review and meta-analysisSami Taleghani, Cecilie C Sørensen, Jasmin Dam Lukoschewitz, et al.
Journal of Critical Care|December 27, 2018
Mean arterial pressure during targeted temperature management and renal function after out-of-hospital cardiac arrestJohannes Grand, Christian Hassager, Matilde Winther-Jensen, et al.
European Heart Journal. Acute Cardiovascular Care|April 29, 2017
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patientsLaust Obling, Martin Frydland, Rikke Hansen, et al.
Shock (Augusta, Ga.)|May 7, 2019
Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial InfarctionAnika Klein, Sebastian Wiberg, Christian Hassager, et al.
Resuscitation|January 29, 2015
Target temperature management of 33°C and 36°C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm - a TTM sub-studyMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
European Heart Journal. Acute Cardiovascular Care|January 22, 2020
Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarctionMartin Frydland, Jacob E Møller, Matias G Lindholm, et al.
Pageof 7